EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A retrospective study on the impact of glucocorticoids on the efficacy of posaconazole in the prevention/treatment of invasive fungal infections in patients with hematological malignancies

Shizhao Yuan, Shuai Liu, Yan Zhao, Ziyi Wang, Yan Liu, Jing Yu

Precision Medication · 2025

DOI: 10.1016/j.prmedi.2024.100013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Precision Medication, 2025. Verfasst von Shizhao Yuan und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hebei Province Medical Science Research Key Project.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Posaconazole (PCZ) has been used to prevent and treat invasive fungal infections in immunocompromised patients with hematological malignancies. There is a significant correlation between plasma drug concentration and the efficacy of posaconazole. This study aimed to investigate the effects of glucocorticoid on PCZ C min and on the outcome of PCZ prevention/treatment of invasive fungal infections. We conducted a retrospective study at a tertiary hospital, examining patients who were administered posaconazole oral suspension between September 2021 and September 2023, to assess the effect of glucocorticoid on the plasma drug concentration and antifungal effect of posaconazole. (Ⅰ) The concomitant usage of glucocorticoid reduced PCZ C min from 1310.00 (648.48,2550.00) ng/mL to 1085.00 (529.79,1767.50) ng/mL (p = 0.032), and the C min /Dose (C/D) decreased from 2.14 (0.98, 4.10) ng/mL/mg to 1.66 (0.86, 2.73) ng/mL/mg (p = 0.038). (Ⅱ) There was a significant difference in PCZ C min between patients on low-dose glucocorticoids and those on medium & high-dose glucocorticoids (1271.14 vs 720.19 ng/mL, p < 0.001). (Ⅲ) PCZ C min was significantly lower in patients with longer glucocorticoid duration than with shorter (p = 0.013). (Ⅳ) Compared with PCZ alone, the concomitant usage of PPIs, glucocorticoids, and PPIs & glucocorticoids significantly reduced PCZ C min (p < 0.001, p= 0.001, p= 0.001). The concomitant usage of glucocorticoid can significantly reduce PCZ C min , and this decrease has a correlation with the dose and duration of glucocorticoid. However, glucocorticoid may not affect the clinical outcome of posaconazole in the prevention/treatment of invasive fungal infections.

Förderung

  • Hebei Province Medical Science Research Key Project

Zitieren

APA

Yuan, S., Liu, S., Zhao, Y., Wang, Z., Liu, Y., & Yu, J. (2025). A retrospective study on the impact of glucocorticoids on the efficacy of posaconazole in the prevention/treatment of invasive fungal infections in patients with hematological malignancies. Precision Medication. https://doi.org/10.1016/j.prmedi.2024.100013

Vancouver

Yuan S, Liu S, Zhao Y, Wang Z, Liu Y, Yu J. A retrospective study on the impact of glucocorticoids on the efficacy of posaconazole in the prevention/treatment of invasive fungal infections in patients with hematological malignancies. Precision Medication. 2025. doi:10.1016/j.prmedi.2024.100013

BibTeX
@article{Yuan2025,
  author = {Yuan, Shizhao and Liu, Shuai and Zhao, Yan and Wang, Ziyi and Liu, Yan and Yu, Jing},
  title = {A retrospective study on the impact of glucocorticoids on the efficacy of posaconazole in the prevention/treatment of invasive fungal infections in patients with hematological malignancies},
  journal = {Precision Medication},
  year = {2025},
  doi = {10.1016/j.prmedi.2024.100013}
}
Kostenlos starten →